McRae Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $334K | Hold |
1,275
| – | – | 0.06% | 90 |
|
|
2026
Q2 | $321K | Hold |
1,275
| – | – | 0.06% | 90 |
|
|
2026
Q1 | $277K | Hold |
1,275
| – | – | 0.06% | 93 |
|
|
2025
Q4 | $291K | Sell |
1,275
-24
| -2% | -$5.47K | 0.06% | 90 |
|
|
2025
Q3 | $301K | Hold |
1,299
| – | – | 0.06% | 90 |
|
|
2025
Q2 | $241K | Hold |
1,299
| – | – | 0.05% | 95 |
|
|
2025
Q1 | $272K | Sell |
1,299
-665
| -34% | -$129K | 0.06% | 84 |
|
|
2024
Q4 | $349K | Hold |
1,964
| – | – | 0.07% | 78 |
|
|
2024
Q3 | $388K | Buy |
1,964
+24
| +1% | +$4.48K | 0.08% | 74 |
|
|
2024
Q2 | $333K | Sell |
1,940
-800
| -29% | -$133K | 0.08% | 76 |
|
|
2024
Q1 | $499K | Sell |
2,740
-26
| -0.9% | -$4.48K | 0.11% | 65 |
|
|
2023
Q4 | $429K | Hold |
2,766
| – | – | 0.11% | 66 |
|
|
2023
Q3 | $412K | Hold |
2,766
| – | – | 0.12% | 67 |
|
|
2023
Q2 | $373K | Buy |
2,766
+26
| +0.9% | +$3.81K | 0.11% | 68 |
|
|
2023
Q1 | $437K | Hold |
2,740
| – | – | 0.13% | 65 |
|
|
2022
Q4 | $443K | Hold |
2,740
| – | – | 0.13% | 68 |
|
|
2022
Q3 | $368K | Sell |
2,740
-17
| -0.6% | -$2.44K | 0.11% | 71 |
|
|
2022
Q2 | $422K | Buy |
2,757
+65
| +2% | +$9.93K | 0.11% | 65 |
|
|
2022
Q1 | $436K | Hold |
2,692
| – | – | 0.1% | 75 |
|
|
2021
Q4 | $364K | Sell |
2,692
-20
| -0.7% | -$2.36K | 0.08% | 83 |
|
|
2021
Q3 | $293K | Sell |
2,712
-100
| -4% | -$11.4K | 0.06% | 93 |
|
|
2021
Q2 | $317K | Sell |
2,812
-5
| -0.2% | -$563 | 0.07% | 87 |
|
|
2021
Q1 | $305K | Hold |
2,817
| – | – | 0.08% | 82 |
|
|
2020
Q4 | $302K | Hold |
2,817
| – | – | 0.09% | 76 |
|
|
2020
Q3 | $247K | Hold |
2,817
| – | – | 0.08% | 81 |
|
|
2020
Q2 | $277K | Sell |
2,817
-19
| -0.7% | -$1.67K | 0.1% | 73 |
|
|
2020
Q1 | $216K | Buy |
2,836
+419
| +17% | +$35.7K | 0.11% | 80 |
|
|
2019
Q4 | $214K | Buy |
+2,417
| New | +$201K | 0.08% | 92 |
|
|
2019
Q3 | – | Sell |
-3,117
| Closed | -$227K | – | 92 |
|
|
2019
Q2 | $227K | Sell |
3,117
-100
| -3% | -$7.86K | 0.09% | 87 |
|
|
2019
Q1 | $259K | Sell |
3,217
-965
| -23% | -$78.9K | 0.11% | 78 |
|
|
2018
Q4 | $386K | Sell |
4,182
-1,000
| -19% | -$87.9K | 0.2% | 59 |
|
|
2018
Q3 | $490K | Buy |
5,182
+250
| +5% | +$23.7K | 0.21% | 52 |
|
|
2018
Q2 | $457K | Buy |
4,932
+740
| +18% | +$72.3K | 0.19% | 62 |
|
|
2018
Q1 | $397K | Buy |
4,192
+100
| +2% | +$11K | 0.18% | 60 |
|
|
2017
Q4 | $396K | Hold |
4,092
| – | – | 0.17% | 63 |
|
|
2017
Q3 | $364K | Hold |
4,092
| – | – | 0.16% | 64 |
|
|
2017
Q2 | $297K | Hold |
4,092
| – | – | 0.12% | 77 |
|
|
2017
Q1 | $267K | Sell |
4,092
-1,000
| -20% | -$62.9K | 0.11% | 80 |
|
|
2016
Q4 | $319K | Buy |
5,092
+500
| +11% | +$30.5K | 0.14% | 76 |
|
|
2016
Q3 | $290K | Sell |
4,592
-650
| -12% | -$42.1K | 0.13% | 82 |
|
|
2016
Q2 | $325K | Buy |
+5,242
| New | +$319K | 0.15% | 74 |
|
Other funds holding ABBV
McRae Capital Management's ABBV Position: Q3 2026 in Review
McRae Capital Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,275 shares worth $334K. The position accounts for 0.06% of the portfolio, ranked #90.
McRae Capital Management first reported a position in ABBV in Q2 2016 and has held it in 41 quarters since. The position peaked at $499K in Q1 2024. 653 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- McRae Capital Management held 1,275 shares of AbbVie worth $334K as of Q3 2026.
- McRae Capital Management left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.06% of McRae Capital Management's portfolio in Q3 2026, its #90 holding.
- McRae Capital Management first reported a position in AbbVie in Q2 2016 and has held it in 41 quarters since.
- McRae Capital Management's AbbVie position peaked at $499K in Q1 2024.
- 653 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on McRae Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.